quetiapine-fumarate and Lung-Neoplasms

This is a complex case of post-traumatic stress disorder (PTSD) with comorbid panic disorder occurring in a woman in her mid-60s, with a family history of neurotic illness. PTSD arose in the context of treatment for terminal lung cancer. This patient who had been close to her father watched him die of cancer, when he was about her age. Her diagnosis and treatment prompted traumatic recollections of her father's illness and death that resulted in her voluntary withdrawal from cancer treatment. The goals of treatment were to promptly reduce anxiety, minimise use of sedating pharmacotherapy, promote lucidity and prolong anxiety-free state thereby allowing time for important family interactions. Prompt, sustained relief of severe anxiety was necessary to achieve comfort at the end of life. Skilled additions of psychological therapies (eye movement desensitisation reprocessing, clinical hypnosis and breathing exercises) with combined pharmacotherapy (mirtazepine and quetiapine) led to control of anxiety and reduction of post-traumatic stress.

Topics: Anti-Anxiety Agents; Anxiety; Breathing Exercises; Comorbidity; Death; Dibenzothiazepines; Eye Movement Desensitization Reprocessing; Female; Humans; Hypnosis; Lung Neoplasms; Mianserin; Middle Aged; Mirtazapine; Palliative Care; Panic Disorder; Quetiapine Fumarate; Stress Disorders, Post-Traumatic; Terminal Care

Topics: Adult; Antipsychotic Agents; Biopsy; Delayed Diagnosis; Dermoscopy; Dibenzothiazepines; Disease Progression; Fatal Outcome; Humans; Lung Neoplasms; Male; Melanoma; Quetiapine Fumarate; Schizophrenia, Paranoid; Shoulder; Skin Neoplasms